When was azstarys approved?

Azstarys was approved by the U.S. Food and Drug Administration (FDA) on April 12, 2021 [1].

What is Azstarys used for?

Azstarys is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in people aged 13 years and older [1]. It is a central nervous system stimulant [2].

How does Azstarys work?

Azstarys contains two active ingredients: serdexymethylphenidate and dexmethylphenidate [1]. Serdexmethylphenidate is a prodrug that is converted in the body to dexmethylphenidate [3]. Dexmethylphenidate works by increasing the levels of dopamine and norepinephrine in the brain, which are neurotransmitters that play a role in attention and impulse control [2][3].

When does Azstarys patent exclusivity end?

Information regarding the specific patent exclusivity for Azstarys is available through resources like DrugPatentWatch.com [4]. Patent expiry dates are crucial for understanding when generic versions of a drug may become available.

Who manufactures Azstarys?

Azstarys is manufactured by Corium Inc. [1].